The circadian factor Period 2 modulates p53 stability and transcriptional activity in unstressed cells.
Level 5 - mechanism / opinion, no new human data
Bench research / in vitro molecular study (Level 5 by CEBM design criteria)
PubMed 25103245 · doi:10.1091/mbc.E14-05-0993
What was done
The authors examined the molecular mechanism connecting the circadian clock regulator human Period 2 (hPer2) to the tumor suppressor human p53 (hp53) and its negative regulator Mdm2. They conducted binding assays, ubiquitination and degradation experiments, and altered hPer2 expression levels (down-regulation and overexpression) in unstressed cells to evaluate effects on hp53 protein stability and target gene transcription.
What was found
The abstract reports no numerical values, confidence intervals, or statistical tests. Qualitatively, hPer2 bound to the C-terminal half of hp53, forming a stable trimeric complex with Mdm2. This interaction prevented Mdm2 ubiquitination and proteasomal degradation of hp53. Down-regulation of hPer2 decreased hp53 levels, while hPer2 overexpression increased hp53 stability and activated transcription of its target genes.
Why it matters
The study identifies a direct checkpoint mechanism coupling core circadian proteins to basal p53 regulation, explaining how the circadian clock pre-conditions cells for rapid DNA damage responses.
Limits
The abstract contains no quantitative metrics or effect sizes. All data are derived from in vitro/cellular models under unstressed conditions, leaving physiological dynamics in living organisms and clinical tumor contexts uncharacterized.
Cited by
- supports DNA repair mechanisms and tumor suppressor genes in the human body are regulated by circadian biology.